Developing vaccines to fight antibiotic-resistant bacteria
Official title: Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
Funded at Eveliqure Biotechnologies, Gmbh · NIH-11304057 · Data updated 2026-11-12
This study is working on a new vaccine to help fight bacteria that don't respond to regular antibiotics, and it will eventually involve people to see how safe and effective the vaccine is.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Eveliqure Biotechnologies, Gmbh NIH-funded |
| Lab location | 1 site (Veinna, Austria) |
| Project start | September 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $3,964,191 |
| NIH project number | 75N93020C00048-P00012-9999-1 |
| Project ID | NIH-11304057 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would be individuals at high risk for infections caused by antibiotic-resistant bacteria.
✕Less likely to help
Patients who are not at risk for antibiotic-resistant infections or those who are already infected may not benefit from this research.
What this research studies
This research focuses on creating a vaccine to combat bacteria that have become resistant to antibiotics. The project involves formulating and manufacturing vaccine components, conducting stability tests, and evaluating the vaccine's effectiveness and safety through animal models. It also includes a Phase 2 clinical trial to assess how well the vaccine works in humans. Patients may be involved in later stages of testing to determine the vaccine's safety and efficacy.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that prevent infections from antibiotic-resistant bacteria, improving patient outcomes.
How similar studies have gone: Other research has shown promise in developing vaccines against antibiotic-resistant bacteria, indicating potential for success in this area.
Where this research is happening
-
Eveliqure Biotechnologies, Gmbh
Veinna, Austria Active
Researchers
- Principal investigator: Malinowski, Frank — Eveliqure Biotechnologies, Gmbh
- Study coordinator: Malinowski, Frank
Related research
Other NIH-funded projects on the same topics.
-
Developing vaccines to fight antibiotic-resistant bacteria
This study is working on new vaccines to help fight infections caused by bacteria that don't respond to regular antibiotics, and it's designed for people who want to help improve treatments for serious infections.
-
Developing vaccines to fight antibiotic-resistant bacteria
This study is working on developing vaccines to help protect people from infections caused by bacteria that don't respond to regular antibiotics, and it's aimed at making sure these vaccines are safe and effective for future use in humans.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.